Vimta Labs surges on acquiring 100% stake in Emtac Laboratories

05 Mar 2020 Evaluate

Vimta Labs is currently trading at Rs. 91.25, up by 1.00 points or 1.11% from its previous closing of Rs. 90.25 on the BSE.

The scrip opened at Rs. 91.30 and has touched a high and low of Rs. 91.30 and Rs. 91.25 respectively. So far 150 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 219.40 on 11-Mar-2019 and a 52 week low of Rs. 87.60 on 09-Jan-2020.

Last one week high and low of the scrip stood at Rs. 99.00 and Rs. 88.15 respectively. The current market cap of the company is Rs. 203.94 crore.

The promoters holding in the company stood at 37.46%, while Institutions and Non-Institutions held 0.15% and 62.39% respectively.

Vimta Labs has acquired 100% equity shares in Emtac Laboratories.  With this Emtac Laboratories has become a wholly owned subsidiary of the company.

Vimta Labs is India’s leading contract research and testing organization. The company supports regulatory authorities in mandatory certification of food and agri products exported from India.

Vimta Labs Share Price

450.00 -5.65 (-1.24%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.